Comment on: 'Eczematous drug eruption in patients with psoriasis under anti-interleukin-17A: does interleukin-22 play a key role?'

Clin Exp Dermatol. 2022 Dec;47(12):2305. doi: 10.1111/ced.15386. Epub 2022 Sep 25.

Authors

Mengmeng Li¹, Wei Li^{1

2}

Affiliations

¹ Department of Dermatology, West China Hospital, Sichuan University, Chengdu, China.
² Department of Dermatology, Rare Diseases Center, West China Hospital, Sichuan University, Chengdu, China.

PMID: 36006173
DOI: 10.1111/ced.15386

No abstract available

Publication types

Letter
Comment

MeSH terms

Drug Eruptions* / etiology
Humans
Interleukin-22
Interleukins
Psoriasis* / drug therapy

Substances

Interleukins